0001209191-18-032803.txt : 20180523
0001209191-18-032803.hdr.sgml : 20180523
20180523215237
ACCESSION NUMBER: 0001209191-18-032803
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180521
FILED AS OF DATE: 20180523
DATE AS OF CHANGE: 20180523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cappel Markus J.
CENTRAL INDEX KEY: 0001422995
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 18856519
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-21
0
0001340652
ChemoCentryx, Inc.
CCXI
0001422995
Cappel Markus J.
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
0
1
0
0
Chief Bus. Officer & Treasurer
Common Stock
2018-05-21
4
M
0
2709
6.00
A
26535
D
Common Stock
2018-05-21
4
S
0
2709
13.00
D
23826
D
Stock Option (Right to buy)
6.00
2018-05-21
4
M
0
2709
D
2009-07-28
2019-07-29
Common Stock
2709
58125
D
Shares sold are associated with stock options that will expire in September 2019.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
As of May 21, 2018, and prior to this transaction, the exercised options were fully vested.
Not applicable.
/s/ Susan M. Kanaya, Attorney-in-Fact
2018-05-23